development efforts. The RV3-BB rotavirus vaccine is a human neonatal rotavirus vaccine under development at Murdoch Childrens Research Institute, Australia. RV3-BB is an oral vaccine targeting birth dose
have also been used as vectors (either replication competent or replication deficient) for development of vaccines against both infectious and non-infectious diseases. The most important factor in the construction…
Many Bacterial components used as immunogen during vaccine development. Plasmid DNA is one among them. It is a short sequence DNA. It always carries one or more genes responsible ... useful characteristics. If use DNA…
quality and the potency of vaccine product from early phase through the late phase vaccine development, even after licensure of the product â?¢ Strategy thinking and planning in the assessment
vaccines for young children will significantly reduce the disease burden in developing world. The Vi polysaccharide based conjugate vaccines (Vi-rEPA) against Salmonella Typhi Vi-positive strains has shown high
half-life technology and manufacturing techniques allows for the development of monoclonal antibodies that can be used as passive vaccines in infants. MEDI8897 is a passive RSV vaccine for preterm
threat of an intentional release of smallpox has led to renewed efforts to develop a safer vaccine, with fewer side effects, that could be administered to the general public ... monkeypox, showing that this vaccine…
funding mechanism for infectious disease focused research, however, to assist academic and industrial developers of vaccines and therapeutics, a series of contracts have been established at the Division of Microbiology…
Editorial Board of Journal of Vaccination & Immunogen Techniques. This is an exciting time for vaccine development since emerging infectious diseases and chronic diseases such as cancer and autoimmune urgently need
Rapid vaccine development has become one of the most important scientific achievements in modern medicine, particu larly during global infectious disease emergencies. This presentation discusses innovative vaccine…
previously controlled infections and increasing antimicrobial resistance continue to challenge global healthcare systems. Vaccine development relied on weakened or inactivated microorganisms to stimulate protective…
This collection of research showcases advancements in veterinary vaccine development, focusing on innovative platforms like subunit, DNA, and mRNA vaccines, as well as novel adjuvants and delivery systems. The studies
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.